v3.26.1
Condensed Statements of Changes in Shareholders’ (Deficit) Equity (Unaudited) - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
 [1]
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2025 $ 767 $ 24,233 $ (21,489) $ 3,511
Balance (in Shares) at Dec. 31, 2025 7,666,667      
Sale of 5,066,666 Private Placement Warrants 7,600,000 7,600,000
Fair value of Public Warrants at issuance 3,020,667 3,020,667
Allocated value of transaction costs to Class A shares 211,721 211,721
Accretion for Class A ordinary shares to redemption amount (10,433,179) (7,191,550) (17,624,729)
Net Income (Loss) 177,312 177,312
Balance at Mar. 31, 2026 $ 767 (7,035,727) (7,034,960)
Balance (in Shares) at Mar. 31, 2026 7,666,667      
Balance at Dec. 31, 2025 $ 767 24,233 (21,489) 3,511
Balance (in Shares) at Dec. 31, 2025 7,666,667      
Net Income (Loss)         1,928,457
Balance at Jun. 30, 2026 $ 767 (7,362,674) (7,361,907)
Balance (in Shares) at Jun. 30, 2026 7,666,667      
Balance at Mar. 31, 2026 $ 767 (7,035,727) (7,034,960)
Balance (in Shares) at Mar. 31, 2026 7,666,667      
Accretion for Class A ordinary shares to redemption amount (2,078,092) (2,078,092)
Net Income (Loss) 1,751,145 1,751,145
Balance at Jun. 30, 2026 $ 767 $ (7,362,674) $ (7,361,907)
Balance (in Shares) at Jun. 30, 2026 7,666,667      
[1] As of December 31, 2025, included up to 1,000,000 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Note 5). On March 13, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 1,000,000 Founder Shares are no longer subject to forfeiture.